United Therapeutics Corporation

Featured

Chuck Hull on 3D Systems’ Journey into Bioprinting 

After 35 years of creating innovative 3D printing technologies, pioneering company 3D Systems (NYSE: DDD) is expanding its bioprinting efforts. Following a successful collaboration with United Therapeutics Corporation dedicated to…

CollPlant Biotechnologies Raise $5.5 Million

Regenerative medicine company CollPlant announced new fundraising of $5.5 million in convertible loans intended to support the advancement of their research projects in the fields of medical aesthetics and 3D…

CollPlant and United Therapeutics Corporation Enter into Licensing Agreement for 3D Bioprinted Lungs

This week, CollPlant and United Therapeutics Corporation announced that they have entered into a licensing, development, and commercialization agreement together for the purposes of 3D bioprinted lung transplants. This partnership will combine United Therapeutics’ organ…

3D Systems and United Therapeutics to Develop 3D Printing Biotechnology for Solid-Organ Scaffolds

No matter how many times I read or write about it, I am still overwhelmed and amazed when I see what 3D printing technology is currently able to do for…